PMID: 24727426

Wang Y, Wrennall JA, Cai Z, Li H, Sheppard DN
Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models.
Int J Biochem Cell Biol. 2014 Jul;52:47-57. doi: 10.1016/j.biocel.2014.04.001. Epub 2014 Apr 13., [PubMed]
Sentences
No. Mutations Sentence Comment
1865 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1865:130
status: NEW
view ABCC7 p.Gly551Asp details
Only one drug that targets mutant CFTR (ivacaftor [KalydecoTM; VX-770]) is available to a small number of CF patients bearing the G551D mutation (Van Goor et al., 2009; Ramsey et al., 2011). Login to comment
1915 ABCC7 p.Arg352Cys
X
ABCC7 p.Arg352Cys 24727426:1915:82
status: NEW
view ABCC7 p.Arg352Cys details
However, Jih et al. (2012) interpreted the sojourns of the CFTR construct Cysless-R352C-CFTR to sub-conductance states to suggest that more than one ATP molecule might be hydrolysed during an open channel burst. Login to comment
1918 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1918:82
status: NEW
view ABCC7 p.Gly551Asp details
It has also been used to provide an explanation for the impact of the CF mutation G551D on channel gating and the action of the CFTR potentiator ivacaftor (see Section 3.3). Login to comment
1947 ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 24727426:1947:108
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 24727426:1947:24
status: NEW
view ABCC7 p.Gly542* details
Common examples include G542X, the second most common CF mutation, prevalent in Mediterranean countries and W1282X, the most common CF mutation in Ashkenazi Jews. Login to comment
1973 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1973:37
status: NEW
view ABCC7 p.Gly551Asp details
The best known class III mutation is G551D, the third commonest CF mutation, associated with a severe disease phenotype (Welsh et al., 2001) and first to be treated with a clinically approved CFTR potentiator (ivacaftor) (Van Goor et al., 2009; Ramsey et al., 2011). Login to comment
1975 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1975:89
status: NEW
view ABCC7 p.Gly551Asp details
Unsurprisingly, therefore replacement of a hydrogen atom by a large acidic side chain in G551D has devastating consequences for CFTR channel gating (Li et al., 1996; Cai et al., 2006; Bompadre et al., 2007). Login to comment
1976 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1976:61
status: NEW
view ABCC7 p.Gly551Asp details
Bompadre et al. (2007) argue that the molecular basis of the G551D mutation is not the prevention of ATP binding at site 2, but the obstruction of conformational changes subsequent to ATP binding that gate the channel pore. Login to comment
1977 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1977:79
status: NEW
view ABCC7 p.Gly551Asp details
In support of this idea, the authors demonstrated that the gating behaviour of G551D represents the spontaneous ATP-independent activity of wild-type CFTR (Bompadre et al., 2007). Login to comment
1978 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1978:77
status: NEW
view ABCC7 p.Gly551Asp details
Interestingly, ivacaftor enhances strongly ATP-independent channel gating by G551D-CFTR (Eckford et al., 2012; Jih and Hwang, 2013). Login to comment
1981 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1981:61
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 24727426:1981:31
status: NEW
view ABCC7 p.Gly1349Asp details
Interestingly, the CF mutation G1349D is the mirror image of G551D in ATP-binding site 1. Login to comment
1982 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1982:16
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 24727426:1982:23
status: NEW
view ABCC7 p.Gly1349Asp details
In contrast, to G551D, G1349D retains some ATP-dependence, albeit with an altered relationship between ATP concentration and channel activity (Bompadre et al., 2007). Login to comment
1983 ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 24727426:1983:22
status: NEW
view ABCC7 p.Gly1349Asp details
The data suggest that G1349D disrupts CFTR function by hindering NBD dimerization (Bompadre et al., 2007). Login to comment
1984 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1984:55
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 24727426:1984:65
status: NEW
view ABCC7 p.Gly1349Asp details
Our own studies demonstrate that with some differences G551D and G1349D disrupt severely channel gating by decreasing the duration of channel openings and prolonging greatly the long closures that separate channel openings (Fig. 4) (Cai et al., 2006). Login to comment
1985 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1985:23
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 24727426:1985:38
status: NEW
view ABCC7 p.Gly1349Asp details
They also suggest that G551D-CFTR and G1349D-CFTR have distinct pharmacological profiles based on their responses to phloxine B, pyrophosphate and 2-deoxy-ATP, three agents that potentiate channel gating by different mechanisms (Cai et al., 2006). Login to comment
1986 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1986:84
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 24727426:1986:99
status: NEW
view ABCC7 p.Gly1349Asp details
By contrast, Yu et al. (2012) demonstrated that ivacaftor potentiated robustly both G551D-CFTR and G1349D-CFTR with similar potency, but different efficacy. Login to comment
1987 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24727426:1987:138
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg668Cys
X
ABCC7 p.Arg668Cys 24727426:1987:150
status: NEW
view ABCC7 p.Arg668Cys details
ABCC7 p.Ala1067Thr
X
ABCC7 p.Ala1067Thr 24727426:1987:165
status: NEW
view ABCC7 p.Ala1067Thr details
Encouragingly, the data suggest that ivacaftor potentiates multiple gating mutants located in different parts of CFTR structure including R117H (M2), R668C (RD) and A1067T (ICL4) (Yu et al., 2012; Van Goor et al., 2014). Login to comment
1988 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24727426:1988:105
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 24727426:1988:117
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 24727426:1988:132
status: NEW
view ABCC7 p.Arg347Pro details
3.4. Class IV mutations: defective channel conduction Analysis of three CF-PS mutations located in MSD1 (R117H [M2], R334W [M6] and R347P [M6]) provided the first evidence that some CF mutations perturb anion flow through the CFTR pore (Fig. 3). Login to comment
1991 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24727426:1991:4
status: NEW
view ABCC7 p.Arg117His details
For R117H, the reduction was Fig. 4. Login to comment
1993 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:1993:218
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Gly1349Asp
X
ABCC7 p.Gly1349Asp 24727426:1993:198
status: NEW
view ABCC7 p.Gly1349Asp details
(A) Representative single-channel recordings of wild-type CFTR and the indicated CF mutants in excised inside-out membrane patches (number of active channels (N): wild-type and F508del-CFTR, N = 1; G1349D-CFTR, N = 2; G551D-CFTR, N > 4). Login to comment
1998 ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 24727426:1998:41
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 24727426:1998:14
status: NEW
view ABCC7 p.Arg347Pro details
~15%, but for R347P, it was ~70% and for R334W, discrete channel openings were not resolved (Sheppard et al., 1993). Login to comment
1999 ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 24727426:1999:50
status: NEW
view ABCC7 p.Arg334Trp details
Later, Gong and Linsdell (2004) demonstrated that R334W reduced single-channel conductance by ~60% by impeding ion-ion interactions within the CFTR pore. Login to comment
2002 ABCC7 p.Arg334Leu
X
ABCC7 p.Arg334Leu 24727426:2002:45
status: NEW
view ABCC7 p.Arg334Leu details
ABCC7 p.Arg334Gln
X
ABCC7 p.Arg334Gln 24727426:2002:55
status: NEW
view ABCC7 p.Arg334Gln details
Mutation of R334, including the CF mutations R334L and R334Q, transformed the current-voltage (I-V) relationship of CFTR from linear (or quasi-linear, see Cai et al., 2003) to strongly inwardly rectifying (Smith et al., 2001; Gong and Linsdell, 2003). Login to comment
2005 ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 24727426:2005:29
status: NEW
view ABCC7 p.Arg347His details
By contrast, the CF mutation R347H reduced single-channel conductance, converting CFTR to a single-ion pore. Login to comment
2011 ABCC7 p.Pro99Leu
X
ABCC7 p.Pro99Leu 24727426:2011:29
status: NEW
view ABCC7 p.Pro99Leu details
ABCC7 p.Pro99Leu
X
ABCC7 p.Pro99Leu 24727426:2011:233
status: NEW
view ABCC7 p.Pro99Leu details
For example, the CF mutation P99L, which affects a residue that faces away from the pore (Akabas et al., 1994; Gao et al., 2013, but see Wang et al., 2011), had an altered anion selectivity sequence (wild-type: Br- ࣙ Cl- > I-; P99L: Br- ࣙ Cl- = I-) and reduced single-channel conductance (Sheppard et al., 1996). Login to comment
2012 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24727426:2012:25
status: NEW
view ABCC7 p.Arg117His details
Although the CF mutation R117H is classified as a class IV mutation, it is principally a gating mutation, reducing channel activity (measured by open probability [Po]) to ~30% wild-type levels, but single-channel conductance by only ~15% (Sheppard et al., 1993). Login to comment
2013 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24727426:2013:34
status: NEW
view ABCC7 p.Arg117His details
Further analyses of the impact of R117H on CFTR channel gating are required. Login to comment
2014 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24727426:2014:121
status: NEW
view ABCC7 p.Gly551Asp details
However, visual inspection of single-channel records suggests that the pattern of channel gating is different to that of G551D-CFTR, where the interburst interval is prolonged greatly (see Section 3.3). Login to comment
2015 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24727426:2015:22
status: NEW
view ABCC7 p.Arg117His details
The data suggest that R117H destabilises the open-channel configuration with the result that the pattern of channel gating bears some resemblance to that of wild-type CFTR inhibited by intermediate speed open-channel blockers (e.g. glibenclamide; Sheppard and Robinson, 1997). Login to comment
2016 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24727426:2016:137
status: NEW
view ABCC7 p.Arg117His details
Of note, H&#e4;mmerle et al. (2001) systematically investigated the impact of ten CF mutations in extracellular loop 1 (ECL1), including R117H, on CFTR expression and function. Login to comment
2017 ABCC7 p.Pro111Leu
X
ABCC7 p.Pro111Leu 24727426:2017:113
status: NEW
view ABCC7 p.Pro111Leu details
All the ECL1 CF mutants studied were correctly processed, some affected Cl-conductance and with the exception of P111L, all perturbed channel gating. Login to comment
2023 ABCC7 p.Gly178Arg
X
ABCC7 p.Gly178Arg 24727426:2023:45
status: NEW
view ABCC7 p.Gly178Arg details
ABCC7 p.His620Gln
X
ABCC7 p.His620Gln 24727426:2023:55
status: NEW
view ABCC7 p.His620Gln details
Interestingly, the authors demonstrated that G178R and H620Q, two CF-PI mutations that disrupt cellular HCO3 - transport, were without effect on CFTR-mediated HCO3 - transport, arguing that CF mutations influence HCO3 --transport indirectly. Login to comment
2026 ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 24727426:2026:283
status: NEW
view ABCC7 p.Ala455Glu details
This class of CF mutations includes promoter mutations that alter transcription (e.g. 125 G࢐C), nucleotide changes that promote alterative splicing of CFTR transcripts (e.g. 3849 + 10 kb C࢐T) and amino acid substitutions, which cause inefficient protein maturation (e.g. A455E) (Zielenski and Tsui, 1995). Login to comment
2028 ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 24727426:2028:28
status: NEW
view ABCC7 p.Ala455Glu details
This idea is exemplified by A455E, the first CF-PS mutation to be associated with milder lung disease (Gan et al., 1995). Login to comment
2029 ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 24727426:2029:36
status: NEW
view ABCC7 p.Ala455Glu details
When studied in heterologous cells, A455E-CFTR disrupted the processing and intracellular transport of CFTR, albeit not as severely as F508del-CFTR (Sheppard et al., 1995). Login to comment
2030 ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 24727426:2030:61
status: NEW
view ABCC7 p.Ala455Glu details
However, the conduction, permeation and gating properties of A455E-CFTR were almost indistinguishable from those of wild-type CFTR (Sheppard et al., 1995). Login to comment
2031 ABCC7 p.Pro574His
X
ABCC7 p.Pro574His 24727426:2031:41
status: NEW
view ABCC7 p.Pro574His details
Even more notable was the CF-PS mutation P574H, which disrupted CFTR processing, but formed a "super" normal channel, distinguished by greatly prolonged, but less frequent channel openings compared to wild-type CFTR (Sheppard et al., 1995; Champigny et al., 1995). Login to comment
2033 ABCC7 p.Gln1412*
X
ABCC7 p.Gln1412* 24727426:2033:32
status: NEW
view ABCC7 p.Gln1412* details
For example, the CF-PI mutation Q1412X, which truncates the last 70 amino acids of CFTR, generated macroscopic cAMP-stimulated Cl-currents with similar biophysical properties, but reduced magnitude compared to wild-type CFTR (Haardt et al., 1999). Login to comment
2034 ABCC7 p.Gln1412*
X
ABCC7 p.Gln1412* 24727426:2034:38
status: NEW
view ABCC7 p.Gln1412* details
ABCC7 p.Gln1412*
X
ABCC7 p.Gln1412* 24727426:2034:216
status: NEW
view ABCC7 p.Gln1412* details
Biochemical studies demonstrated that Q1412X was without effect on CFTR processing and intracellular transport, but greatly reduced the stability of mature CFTR protein (half-life in COS cells: wild-type CFTR, 14 h; Q1412X, 3.5 h). Login to comment